Literature DB >> 8920870

Involvement of Interleukin (IL) 8 receptor in negative regulation of myeloid progenitor cells in vivo: evidence from mice lacking the murine IL-8 receptor homologue.

H E Broxmeyer1, S Cooper, G Cacalano, N L Hague, E Bailish, M W Moore.   

Abstract

Expansion of mature neutrophils has been observed in mice lacking the murine interleukin (IL) 8 receptor homolog [mIL-8Rh(-/-)], and human (hu) IL-8 suppresses proliferation of primitive myeloid cells in vitro and in vivo. To evaluate involvement and relevance of murine IL-8 receptor homolog (mIL-8Rh) in negative regulation of myelopoiesis, we studied mIL-8Rh(-/-) and (+/+) mice raised in a normal or germ-free environment. Immature myeloid progenitors from mIL-8Rh(+/+) mice bred under normal or germ-free conditions were significantly suppressed in vitro by recombinant huIL-8, macrophage inflammatory protein (MIP)-1 alpha, platelet factor (PF) 4, interferon inducible protein (IP) 10, monocyte chemotactic peptide (MCP) 1, and H-ferritin. In contrast, progenitors from mIL-8Rh(-/-) mice were insensitive to inhibition by IL-8, but not to these other chemokines and H-ferritin. Mouse MIP-2, a ligand for mIL-8Rh, suppressed progenitors from normal but not mIL-8Rh(-/-) mice. Under normal environmental conditions, enhanced numbers of myeloid progenitors were found in femur, spleen, and blood of mIL-8Rh(-/-) compared with mIL-8Rh(+/+) mice. Numbers of myeloid progenitors were greatly decreased in mIL-8Rh(-/-)and (+/+) mice in germ-free conditions, and were either not significantly enhanced in mIL-8Rh(-/-) mice compared with (+/+) mice or were only moderately so. Differences in progenitors/organ between a germ-free and normal environment were greater for the mIL-8Rh(-/-) mice. These results document selective insensitivity of myeloid progenitor cells from mIL-8Rh(-/-) mice to inhibition by huIL-8 and mouse MIP-2 and a large expansion of myeloid progenitors in these mice, the latter effect being environmentally inducible. This provides strong support for a negative myeloid regulatory role played by the mIL-8Rh in vivo, whose active ligand may be MIP-2.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8920870      PMCID: PMC2192871          DOI: 10.1084/jem.184.5.1825

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  28 in total

Review 1.  Interleukin-8 and related chemotactic cytokines--CXC and CC chemokines.

Authors:  M Baggiolini; B Dewald; B Moser
Journal:  Adv Immunol       Date:  1994       Impact factor: 3.543

2.  Comparative analysis of the human macrophage inflammatory protein family of cytokines (chemokines) on proliferation of human myeloid progenitor cells. Interacting effects involving suppression, synergistic suppression, and blocking of suppression.

Authors:  H E Broxmeyer; B Sherry; S Cooper; L Lu; R Maze; M P Beckmann; A Cerami; P Ralph
Journal:  J Immunol       Date:  1993-04-15       Impact factor: 5.422

3.  Neutrophil and B cell expansion in mice that lack the murine IL-8 receptor homolog.

Authors:  G Cacalano; J Lee; K Kikly; A M Ryan; S Pitts-Meek; B Hultgren; W I Wood; M W Moore
Journal:  Science       Date:  1994-07-29       Impact factor: 47.728

4.  Structure and functional expression of a human interleukin-8 receptor.

Authors:  W E Holmes; J Lee; W J Kuang; G C Rice; W I Wood
Journal:  Science       Date:  1991-09-13       Impact factor: 47.728

5.  High activity suppression of myeloid progenitor proliferation by chimeric mutants of interleukin 8 and platelet factor 4.

Authors:  T J Daly; G J LaRosa; S Dolich; T E Maione; S Cooper; H E Broxmeyer
Journal:  J Biol Chem       Date:  1995-10-06       Impact factor: 5.157

6.  Comparative effects of suppressive cytokines on isolated single CD34(3+) stem/progenitor cells from human bone marrow and umbilical cord blood plated with and without serum.

Authors:  L Lu; M Xiao; S Grigsby; W X Wang; B Wu; R N Shen; H E Broxmeyer
Journal:  Exp Hematol       Date:  1993-10       Impact factor: 3.084

7.  Molecular characterization of receptors for human interleukin-8, GRO/melanoma growth-stimulatory activity and neutrophil activating peptide-2.

Authors:  D P Cerretti; C J Kozlosky; T Vanden Bos; N Nelson; D P Gearing; M P Beckmann
Journal:  Mol Immunol       Date:  1993-03       Impact factor: 4.407

8.  Chemokine binding and activities mediated by the mouse IL-8 receptor.

Authors:  J Lee; G Cacalano; T Camerato; K Toy; M W Moore; W I Wood
Journal:  J Immunol       Date:  1995-08-15       Impact factor: 5.422

9.  Mechanisms of leukocyte production and release. XII. A comparative assay of the leukocytosis-inducing factor (LIF) and the colony-stimulating factor (CSF).

Authors:  H Broxmeyer; G Van Zant; J R Zucali; J LoBue; A S Gordon
Journal:  Proc Soc Exp Biol Med       Date:  1974-04

10.  Human interferon-inducible protein 10: expression and purification of recombinant protein demonstrate inhibition of early human hematopoietic progenitors.

Authors:  A H Sarris; H E Broxmeyer; U Wirthmueller; N Karasavvas; S Cooper; L Lu; J Krueger; J V Ravetch
Journal:  J Exp Med       Date:  1993-09-01       Impact factor: 14.307

View more
  32 in total

Review 1.  Regulation of hematopoiesis by chemokine family members.

Authors:  H E Broxmeyer
Journal:  Int J Hematol       Date:  2001-07       Impact factor: 2.490

Review 2.  Regulation of neutrophil trafficking from the bone marrow.

Authors:  Ryan B Day; Daniel C Link
Journal:  Cell Mol Life Sci       Date:  2011-11-02       Impact factor: 9.261

3.  Secreted nuclear protein DEK regulates hematopoiesis through CXCR2 signaling.

Authors:  Maegan L Capitano; Nirit Mor-Vaknin; Anjan K Saha; Scott Cooper; Maureen Legendre; Haihong Guo; Rafael Contreras-Galindo; Ferdinand Kappes; Maureen A Sartor; Christopher T Lee; Xinxin Huang; David M Markovitz; Hal E Broxmeyer
Journal:  J Clin Invest       Date:  2019-05-20       Impact factor: 14.808

4.  Infection with Anaplasma phagocytophilum induces multilineage alterations in hematopoietic progenitor cells and peripheral blood cells.

Authors:  J L Johns; K C Macnamara; N J Walker; G M Winslow; D L Borjesson
Journal:  Infect Immun       Date:  2009-06-29       Impact factor: 3.441

5.  Targeted disruption of the beta-chemokine receptor CCR1 protects against pancreatitis-associated lung injury.

Authors:  C Gerard; J L Frossard; M Bhatia; A Saluja; N P Gerard; B Lu; M Steer
Journal:  J Clin Invest       Date:  1997-10-15       Impact factor: 14.808

6.  IL8-CXCR2 pathway inhibition as a therapeutic strategy against MDS and AML stem cells.

Authors:  Carolina Schinke; Orsolya Giricz; Weijuan Li; Aditi Shastri; Shanisha Gordon; Laura Barreyro; Laura Barreryo; Tushar Bhagat; Sanchari Bhattacharyya; Nandini Ramachandra; Matthias Bartenstein; Andrea Pellagatti; Jacqueline Boultwood; Amittha Wickrema; Yiting Yu; Britta Will; Sheng Wei; Ulrich Steidl; Amit Verma
Journal:  Blood       Date:  2015-03-25       Impact factor: 22.113

Review 7.  Interleukin-8 and its receptor CXCR2 in atherosclerosis.

Authors:  W A Boisvert; L K Curtiss; R A Terkeltaub
Journal:  Immunol Res       Date:  2000       Impact factor: 2.829

8.  CXCR2 ligands and G-CSF mediate PKCalpha-induced intraepidermal inflammation.

Authors:  Christophe Cataisson; Andrea J Pearson; Margaret Z Tsien; Francesca Mascia; Ji-Liang Gao; Saveria Pastore; Stuart H Yuspa
Journal:  J Clin Invest       Date:  2006-09-07       Impact factor: 14.808

Review 9.  Role of chemokines in CNS health and pathology: a focus on the CCL2/CCR2 and CXCL8/CXCR2 networks.

Authors:  Bridgette D Semple; Thomas Kossmann; Maria Cristina Morganti-Kossmann
Journal:  J Cereb Blood Flow Metab       Date:  2009-11-11       Impact factor: 6.200

10.  Persistence of Burkholderia multivorans within the pulmonary macrophage in the murine lung.

Authors:  Karen K Chu; Kelly L MacDonald; Donald J Davidson; David P Speert
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.